CAS: 264233-05-8
Ref: IN-DA00C2VK
| 5mg | 242,00 € | ||
| 25mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 5 de Diciembre de 2024
CID 2745687
CAS:264233-05-8
CID 2745687 blocks human GPR35, countering cromolyn disodium & zaprinast effects.
Fórmula:
C17H19F2N5O2S
Pureza:
99.11%
Forma y color:
Solid
Peso molecular:
395.43
Ref: TM-T21874
| 1mg | 40,00 € | ||
| 2mg | 52,00 € | ||
| 5mg | 87,00 € | ||
| 10mg | 123,00 € | ||
| 25mg | 269,00 € | ||
| 50mg | 423,00 € | ||
| 100mg | 628,00 € | ||
| 1mL*10mM (DMSO) | 87,00 € |
Entrega estimada en Estados Unidos, el Jueves 12 de Diciembre de 2024
Methyl 1-(2,4-Difluoro-phenyl)-5-((4-tert-butyl-thiosemicarbazono)methyl)-1H-pyrazole-4-carboxylate
Producto controladoCAS:264233-05-8
Applications Used as a GPR35 antagonist, with potential application towards immune or gastrointestinal system regulation. …
Fórmula:
C17H19F2N5O2S
Forma y color:
Neat
Peso molecular:
395.427
Ref: TR-M301800
| 250mg | 3.618,00 € |
Entrega estimada en Estados Unidos, el Miércoles 15 de Enero de 2025
Methyl 1-(2,4-Difluoro-phenyl)-5-((4-tert-butyl-thiosemicarbazono)methyl)-1H-pyrazole-4-carboxylate
CAS:264233-05-8
Methyl 1-(2,4-difluoro-phenyl)-5-((4-tert-butyl-thiosemicarbazono)methyl)-1H-pyrazole-4-carboxylate (SNX-111) is a drug that has been shown to be useful in the …
Fórmula:
C17H19F2N5O2S
Pureza:
Min. 95%
Peso molecular:
395.43 g/mol
Ref: 3D-FM102381
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 16 de Enero de 2025
